Clinical Evaluation of Extracellular ADMA Concentrations in Human Blood and Adipose Tissue
Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, has been proposed as a biomarker for clinical outcome. Dimethylarginine dimethylaminohydrolase (DDAH) is the main enzyme responsible for ADMA metabolism and elimination. Adipose tissue ADMA concentra...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Molecular Diversity Preservation International (MDPI)
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907863/ |